Acesso livre
Acesso livre

Covid-19 (Temas de Saúde Pública)

Reduzindo o SARS-CoV-2 em ambientes fechados compartilhados.

14 Jun, 2022 | 13:57h

Reducing SARS-CoV-2 in Shared Indoor Air – JAMA


Revisão de escopo | Consequências não intencionais das medidas implementadas no ambiente escolar para conter a pandemia de COVID-19.

14 Jun, 2022 | 13:20h

Unintended consequences of measures implemented in the school setting to contain the COVID‐19 pandemic: a scoping review – Cochrane Library

Resumo: Unintended consequences of school-based measures to manage the COVID-19 pandemic – Cochrane Library


Suplemento | Infecção por Covid-19.

13 Jun, 2022 | 14:22h

Página principal: Covid-19 Infection – Infectious Disease Clinics of North America

Editorial: COVID-19: Where We Are, Where We Need to Be

COVID-19 Pathogenesis and Clinical Manifestations

SARS-CoV-2 Virology

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant

Awakening: The Unveiling of Historically Unaddressed Social Inequities During the COVID-19 Pandemic in the United States

Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care Settings

Laboratory Diagnosis for SARS-CoV-2 Infection

Pharmacologic Treatment and Management of Coronavirus Disease 2019

COVID-19 in the Critically Ill Patient

Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus

COVID-19 and Pregnancy

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children

COVID-19 Vaccines


Estudo de coorte | Acurácia diagnóstica da detecção não invasiva de infecção por SARS-CoV-2 feita por cães farejadores.

6 Jun, 2022 | 11:36h

Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction – PLOS One

Estudo relacionado: Scent dogs in detection of COVID-19: triple-blinded randomised trial and operational real-life screening in airport setting – BMJ Global Health

 

Comentário no Twitter

Sob licença de Creative Commons Attribution License


Metanálise em rede | Efetividade dos regimes heterólogos e homólogos de vacinação contra Covid-19.

2 Jun, 2022 | 14:05h

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis – The BMJ

Comunicado de imprensa: Three doses of the same or mixed covid jabs work equally well against infections – BMJ

Comentário: Three jabs best for preventing Covid infections, global analysis finds – The Guardian


Um sistema de alerta precoce para o surgimento de variantes do SARS-CoV-2.

1 Jun, 2022 | 13:50h

An early warning system for emerging SARS-CoV-2 variants – Nature Medicine

 

Comentário no Twitter

 


Análise/Opinião | As consequências não intencionais da política de vacinas contra COVID-19: “pode ser que mandatos, passaportes e restrições causem mais prejuízos que benefícios.”

31 Mai, 2022 | 12:33h

The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good – BMJ Global Health

 

Comentário no Twitter (fio – clique para saber mais)

 


OMS valida a 11ª vacina contra COVID-19.

23 Mai, 2022 | 13:37h

WHO validates 11th vaccine for COVID-19 – World Health Organization

 

Comentário no Twitter

 


Evidência sobre COVID-19: uma coletânea Cochrane.

23 Mai, 2022 | 13:36h

COVID-19 evidence: a Cochrane round-up – Cochrane Library


Covid-19 | OMS afirma que o segundo reforço de vacina pode ser benéfico em grupos de alto risco, mas tem um impacto “mínimo” para outros grupos.

23 Mai, 2022 | 13:31h

Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO – The BMJ

Diretriz original: Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 – World Health Organization

Recomendações relacionadas:

COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines –
European Centre for Disease Prevention and Control

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals – U.S. Food & Drug Administration


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.